摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4'-methylphenyl)-5-nitrobenzoic acid | 474521-58-9

中文名称
——
中文别名
——
英文名称
2-(4'-methylphenyl)-5-nitrobenzoic acid
英文别名
4'-methyl-4-nitro-[1,1'-biphenyl]-2-carboxylic acid;4'-methyl-4-nitrobiphenyl-2-carboxylic acid;2-(4-Methylphenyl)-5-nitrobenzoic acid
2-(4'-methylphenyl)-5-nitrobenzoic acid化学式
CAS
474521-58-9
化学式
C14H11NO4
mdl
——
分子量
257.246
InChiKey
ILLIWXCGGIHTOC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    83.1
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-(4'-methylphenyl)-5-nitrobenzoic acidN-氯代丁二酰亚胺 、 sodium iodide 作用下, 以 1,2-二氯乙烷 为溶剂, 反应 21.0h, 以87%的产率得到3,4-(2'-nitro)benzo-7-methylcoumarin
    参考文献:
    名称:
    Facile Preparation of 3,4-Benzocoumarins from 2-Arylbenzoic Acids with NCS and Nai
    摘要:
    Treatment of 2-arylbenzoic acids with N-chlorosuccinimide (NCS) and NaI at 70 degrees C under fluorescent lighting condition gave the corresponding 3,4-benzocoumarins in good yields under transition-metal-free condition. It was found that the reactivity of NCS with NaI for the formation of 3,4-benzocoumarins from 2-arylbenzoic acids was as high as that with NIS. Thus, the formation of carboxyl radicals and their cyclization onto an aromatic ring from 2-arylbenzoic acids with much less expensive NCS and NaI, than NIS could be successfully carried out to form 3,4-benzocoumarins.
    DOI:
    10.3987/com-20-14292
  • 作为产物:
    描述:
    3-nitro-N-tosylbenzamidesilver(I) acetate 、 palladium diacetate 、 potassium carbonate溶剂黄146 、 sodium hydroxide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 111.0h, 生成 2-(4'-methylphenyl)-5-nitrobenzoic acid
    参考文献:
    名称:
    N-甲苯磺酰胺作为Pd催化的CH邻位芳基化的可转换方向基
    摘要:
    该Ñ -tosylcarboxamide集团提供引导芳烃提供一个新的项,以biarylcarboxamides的Pd催化的C-H芳基化的可能性。而且,其根据包括分子内反应在内的不同反应条件进行反应的能力使其成为不同的联芳基化合物合成的关键指导基团。
    DOI:
    10.1021/ol3004244
点击查看最新优质反应信息

文献信息

  • Targeting the IspD Enzyme in the MEP Pathway: Identification of a Novel Fragment Class
    作者:Eleonora Diamanti、Mostafa M. Hamed、Antoine Lacour、Patricia Bravo、Boris Illarionov、Markus Fischer、Matthias Rottmann、Matthias Witschel、Anna K. H. Hirsch
    DOI:10.1002/cmdc.202100679
    日期:2022.3.4
    Screening of a part of the BASF library against the PfIspD enzyme led to the identification of a pyrrole as an underexplored chemical scaffold that is able to target the third enzyme in the MEP pathway. A detailed structure–activity relationship (SAR) study around the fragment hit compound helped us to successfully improve the potency as well as the physicochemical properties.
    针对Pf IspD 酶对巴斯夫文库的一部分进行筛选,结果发现吡咯是一种尚未开发的化学支架,能够靶向 MEP 途径中的第三种酶。围绕片段命中化合物进行的详细构效关系 (SAR) 研究帮助我们成功提高了效力和理化性质。
  • Amide compounds
    申请人:——
    公开号:US20040157866A1
    公开(公告)日:2004-08-12
    The present invention relates to compounds of the formula (I) wherein X 1 is wherein R 1 , R 2 and R 10 are independently hydrogen or a suitable substituent; R 11 and R 12 are independently hydrogen or a suitable substituent; R is unsaturated 5 to 6-membered heteromonocyclic group; A is direct bond or —NH—; X 2 is monocyclic arylene, unsaturated 5 to 6-membered heteromonocyclic group or cycloalkenylene; Y is bivalent group selected from ethylene, trimethylene and vinylene, wherein CH 2 is optionally replaced by NH or O, and CH is optionally replaced by N; and Z is —(CH 2 ) n —, —CO—(CH 2 ) m —, —CH═CH— or —CO—NH—, wherein n is 1, 2 or 3 and m is 1 or 2, or a salt thereof. The compounds of the present invention inhibit apolipoprotein B (Apo B) secretion and are useful as a medicament for prophylactic and treatment of diseases or conditions resulting from elevated circulating levels of Apo B. 1
    本发明涉及公式(I)的化合物,其中X1为R1,R2和R10分别为氢原子或适当的取代基;R11和R12分别为氢原子或适当的取代基;R为不饱和的5至6元杂环单环基;A为直接键或—NH—;X2为单环芳烃,不饱和的5至6元杂环单环基或环烯基;Y为乙烯基,三亚甲基或乙烯基中选择的双价基团,其中CH2可以被NH或O替代,CH可以被N替代;Z为—(CH2)n—,—CO—(CH2)m—,—CH=CH—或—CO—NH—,其中n为1、2或3,m为1或2,或其盐。本发明的化合物抑制载脂蛋白B(Apo B)的分泌,并可用作预防和治疗由于Apo B循环水平升高而导致的疾病或病症的药物。
  • Facile Preparation of 3,4-Benzocoumarins from 2-Arylbenzoic Acids with NCS and Nai
    作者:Hideo Togo、Momoko Nakamura
    DOI:10.3987/com-20-14292
    日期:——
    Treatment of 2-arylbenzoic acids with N-chlorosuccinimide (NCS) and NaI at 70 degrees C under fluorescent lighting condition gave the corresponding 3,4-benzocoumarins in good yields under transition-metal-free condition. It was found that the reactivity of NCS with NaI for the formation of 3,4-benzocoumarins from 2-arylbenzoic acids was as high as that with NIS. Thus, the formation of carboxyl radicals and their cyclization onto an aromatic ring from 2-arylbenzoic acids with much less expensive NCS and NaI, than NIS could be successfully carried out to form 3,4-benzocoumarins.
  • <i>N</i>-Tosylcarboxamide as a Transformable Directing Group for Pd-Catalyzed C–H <i>Ortho</i>-Arylation
    作者:Florent Péron、Christine Fossey、Thomas Cailly、Frédéric Fabis
    DOI:10.1021/ol3004244
    日期:2012.4.6
    The N-tosylcarboxamide group offers the possibility of directing the Pd-catalyzed C–H arylation of arenes providing a new entry to biarylcarboxamides. Moreover, its ability to react according to different reaction conditions including intramolecular reactions makes it a pivotal directing group for a divergent synthesis of biaryl-based compounds.
    该Ñ -tosylcarboxamide集团提供引导芳烃提供一个新的项,以biarylcarboxamides的Pd催化的C-H芳基化的可能性。而且,其根据包括分子内反应在内的不同反应条件进行反应的能力使其成为不同的联芳基化合物合成的关键指导基团。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐